Glycemic and Patient-Reported Outcomes for Users of a New, Compact Automated Insulin Delivery System: A First Report.
作者信息
Akturk Halis K, Karakus Kagan E, D'Souza Edwin, Assadi Kimia Z, Pinsker Jordan E, Messer Laurel H
机构信息
Barbara Davis Center for Diabetes, University of Colorado, Denver, CO, USA.
Tandem Diabetes Care, San Diego, CA, USA.
出版信息
J Diabetes Sci Technol. 2025 Mar;19(2):582-583. doi: 10.1177/19322968241302349. Epub 2024 Nov 25.
Abstract
摘要
相似文献
1
Glycemic and Patient-Reported Outcomes for Users of a New, Compact Automated Insulin Delivery System: A First Report.新型紧凑型自动胰岛素输送系统使用者的血糖及患者报告结局：首份报告
J Diabetes Sci Technol. 2025 Mar;19(2):582-583. doi: 10.1177/19322968241302349. Epub 2024 Nov 25.
2
Beneficial Effects of Control-IQ Automated Insulin Delivery in Basal-Bolus and Basal-Only Insulin Users With Type 2 Diabetes.Control-IQ自动胰岛素给药对2型糖尿病基础-餐时胰岛素使用者和仅基础胰岛素使用者的有益效果。
Clin Diabetes. 2024 Winter;42(1):116-124. doi: 10.2337/cd23-0025. Epub 2023 Aug 28.
3
Tandem T:Slim X2 Insulin Pump Use in Clinical Practice Among Pregnant Individuals With Type 1 Diabetes: A Retrospective Observational Cohort Study.串联式T:Slim X2胰岛素泵在1型糖尿病孕妇临床实践中的应用：一项回顾性观察队列研究。
Cureus. 2024 Jan 16;16(1):e52369. doi: 10.7759/cureus.52369. eCollection 2024 Jan.
4
Evaluation of a New Clinical Tool to Enhance Clinical Care of Control-IQ Users.评估一种新的临床工具，以增强 Control-IQ 用户的临床护理。
J Diabetes Sci Technol. 2023 Nov;17(6):1602-1609. doi: 10.1177/19322968221081890. Epub 2022 Feb 28.
5
Real-World Patient-Reported Outcomes and Glycemic Results with Initiation of Control-IQ Technology.基于 Control-IQ 技术的起始治疗的真实世界患者报告结局和血糖结果。
Diabetes Technol Ther. 2021 Feb;23(2):120-127. doi: 10.1089/dia.2020.0388. Epub 2020 Sep 10.
6
One Year Real-World Use of the Control-IQ Advanced Hybrid Closed-Loop Technology.Control-IQ 高级混合闭环技术一年真实世界应用。
Diabetes Technol Ther. 2021 Sep;23(9):601-608. doi: 10.1089/dia.2021.0097. Epub 2021 Apr 21.
7
Safety and Feasibility Evaluation of Automated User Profile Settings Initialization and Adaptation With Control-IQ Technology.基于 Control-IQ 技术的自动用户配置文件设置初始化和自适应的安全性和可行性评估。
J Diabetes Sci Technol. 2024 Nov;18(6):1281-1287. doi: 10.1177/19322968241229074. Epub 2024 Feb 7.
8
Impact of Missed and Late Meal Boluses on Glycemic Outcomes in Automated Insulin Delivery-Treated Children and Adolescents with Type 1 Diabetes: A Two-Center, Population-Based Cohort Study.错过和延迟进餐大剂量胰岛素对接受自动胰岛素输注治疗的 1 型糖尿病儿童和青少年血糖结果的影响：一项基于人群的两中心队列研究。
Diabetes Technol Ther. 2024 Dec;26(12):897-907. doi: 10.1089/dia.2024.0022. Epub 2024 Jun 24.
9
Real-World Use of a New Hybrid Closed Loop Improves Glycemic Control in Youth with Type 1 Diabetes.新型混合闭环在改善青少年 1 型糖尿病患者血糖控制方面的真实世界应用。
Diabetes Technol Ther. 2021 Dec;23(12):837-843. doi: 10.1089/dia.2021.0165. Epub 2021 Jun 21.
10
Safety and Psychological Outcomes of Tandem t:Slim X2 Insulin Pump with Control-IQ Technology in Children, Adolescents, and Young Adults with Type 1 Diabetes: A Systematic Review.1型糖尿病儿童、青少年和年轻成人使用配备Control-IQ技术的串联t:Slim X2胰岛素泵的安全性和心理结局：一项系统评价
Diabetes Ther. 2024 Oct;15(10):2133-2149. doi: 10.1007/s13300-024-01618-2. Epub 2024 Jul 15.
引用本文的文献
1
Registration and Real-Life Studies on Automated Insulin Delivery Systems.自动胰岛素输注系统的注册及真实世界研究
J Diabetes Sci Technol. 2025 Jul;19(4):924-936. doi: 10.1177/19322968251334993. Epub 2025 Jul 1.
2
Control-IQ Technology Provides Similar Glycemic Outcomes Across Two Different CGM Sensors.Control-IQ技术在两种不同的连续血糖监测（CGM）传感器上可实现相似的血糖控制效果。
J Diabetes Sci Technol. 2025 Mar 31:19322968251330308. doi: 10.1177/19322968251330308.
Zotero 插件